Quality of life, alexithymia, and defence mechanisms in patients affected by breast cancer across different stages of illness

Antonio Marrazzo, Daniele La Barbera, Giovanna Marrazzo, Caterina La Cascia, Alice Mulè, Lucia Sideli, Rosalinda Rizzo

Risultato della ricerca: Article

5 Citazioni (Scopus)

Abstract

Objectives: The aim of this study was to evaluate the effect of alexithymia and defence mechanisms on the quality of life of patients affected by breast cancer at different stages of the disease.Methods A convenience sample of 110 patients with breast cancer was involved in the study: 41 were receiving adjuvant chemotherapyafter surgery, 29 had disease-free survival in follow-up and 40 were receiving chemotherapy for metastatic disease. Quality of life, alexithymia and defence mechanisms were assessed using the following instruments: EORTC QLQ-C30-BR23, Toronto Alexithymia Scale (TAS-20) and Defense Mechanism Inventory (DMI). Results Compared to the other groups, patients receiving chemotherapy for metastatic disease reported poorer quality of life in several domains, more severe cancer-related and treatment-related symptoms and higher levels of alexithymia. When the effect of other potential predictors was taken into account, TAS-20 difficulty in identifying feelings was significantly related to all the EORTC functional subscale.Conclusion: This study underlined the relevance of difficulty in emotional processing and defence mechanisms in modulating psychological adjustment in women affected by breast cancer, suggesting that these might be potential targets of psychological intervention for this population.
Lingua originaleEnglish
pagine (da-a)141-148
Numero di pagine8
RivistaJOURNAL OF PSYCHOPATHOLOGY
Volume22
Stato di pubblicazionePublished - 2016

Fingerprint

Affective Symptoms
Defense Mechanisms
Quality of Life
Breast Neoplasms
Drug Therapy
Second Primary Neoplasms
Disease-Free Survival
Emotions
Psychology
Equipment and Supplies
Population

All Science Journal Classification (ASJC) codes

  • Clinical Psychology
  • Psychiatry and Mental health

Cita questo

@article{bbea898a459742c1b5b4f45d58d99e90,
title = "Quality of life, alexithymia, and defence mechanisms in patients affected by breast cancer across different stages of illness",
abstract = "Objectives: The aim of this study was to evaluate the effect of alexithymia and defence mechanisms on the quality of life of patients affected by breast cancer at different stages of the disease.Methods A convenience sample of 110 patients with breast cancer was involved in the study: 41 were receiving adjuvant chemotherapyafter surgery, 29 had disease-free survival in follow-up and 40 were receiving chemotherapy for metastatic disease. Quality of life, alexithymia and defence mechanisms were assessed using the following instruments: EORTC QLQ-C30-BR23, Toronto Alexithymia Scale (TAS-20) and Defense Mechanism Inventory (DMI). Results Compared to the other groups, patients receiving chemotherapy for metastatic disease reported poorer quality of life in several domains, more severe cancer-related and treatment-related symptoms and higher levels of alexithymia. When the effect of other potential predictors was taken into account, TAS-20 difficulty in identifying feelings was significantly related to all the EORTC functional subscale.Conclusion: This study underlined the relevance of difficulty in emotional processing and defence mechanisms in modulating psychological adjustment in women affected by breast cancer, suggesting that these might be potential targets of psychological intervention for this population.",
author = "Antonio Marrazzo and {La Barbera}, Daniele and Giovanna Marrazzo and {La Cascia}, Caterina and Alice Mul{\`e} and Lucia Sideli and Rosalinda Rizzo",
year = "2016",
language = "English",
volume = "22",
pages = "141--148",
journal = "JOURNAL OF PSYCHOPATHOLOGY",
issn = "2284-0249",

}

TY - JOUR

T1 - Quality of life, alexithymia, and defence mechanisms in patients affected by breast cancer across different stages of illness

AU - Marrazzo, Antonio

AU - La Barbera, Daniele

AU - Marrazzo, Giovanna

AU - La Cascia, Caterina

AU - Mulè, Alice

AU - Sideli, Lucia

AU - Rizzo, Rosalinda

PY - 2016

Y1 - 2016

N2 - Objectives: The aim of this study was to evaluate the effect of alexithymia and defence mechanisms on the quality of life of patients affected by breast cancer at different stages of the disease.Methods A convenience sample of 110 patients with breast cancer was involved in the study: 41 were receiving adjuvant chemotherapyafter surgery, 29 had disease-free survival in follow-up and 40 were receiving chemotherapy for metastatic disease. Quality of life, alexithymia and defence mechanisms were assessed using the following instruments: EORTC QLQ-C30-BR23, Toronto Alexithymia Scale (TAS-20) and Defense Mechanism Inventory (DMI). Results Compared to the other groups, patients receiving chemotherapy for metastatic disease reported poorer quality of life in several domains, more severe cancer-related and treatment-related symptoms and higher levels of alexithymia. When the effect of other potential predictors was taken into account, TAS-20 difficulty in identifying feelings was significantly related to all the EORTC functional subscale.Conclusion: This study underlined the relevance of difficulty in emotional processing and defence mechanisms in modulating psychological adjustment in women affected by breast cancer, suggesting that these might be potential targets of psychological intervention for this population.

AB - Objectives: The aim of this study was to evaluate the effect of alexithymia and defence mechanisms on the quality of life of patients affected by breast cancer at different stages of the disease.Methods A convenience sample of 110 patients with breast cancer was involved in the study: 41 were receiving adjuvant chemotherapyafter surgery, 29 had disease-free survival in follow-up and 40 were receiving chemotherapy for metastatic disease. Quality of life, alexithymia and defence mechanisms were assessed using the following instruments: EORTC QLQ-C30-BR23, Toronto Alexithymia Scale (TAS-20) and Defense Mechanism Inventory (DMI). Results Compared to the other groups, patients receiving chemotherapy for metastatic disease reported poorer quality of life in several domains, more severe cancer-related and treatment-related symptoms and higher levels of alexithymia. When the effect of other potential predictors was taken into account, TAS-20 difficulty in identifying feelings was significantly related to all the EORTC functional subscale.Conclusion: This study underlined the relevance of difficulty in emotional processing and defence mechanisms in modulating psychological adjustment in women affected by breast cancer, suggesting that these might be potential targets of psychological intervention for this population.

UR - http://hdl.handle.net/10447/181984

UR - http://www.jpsychopathol.it/wp-content/uploads/2016/05/06_Art_Orig_Sideli1.pdf

M3 - Article

VL - 22

SP - 141

EP - 148

JO - JOURNAL OF PSYCHOPATHOLOGY

JF - JOURNAL OF PSYCHOPATHOLOGY

SN - 2284-0249

ER -